KUALA LUMPUR, Oct 14 (Bernama) -- The demographic shift is expected to drive higher pharmaceutical demand as Malaysia is projected to become an ageing nation by 2036, driven by higher life expectancy and a declining birth rate, according to MBSB Investment Bank Bhd (MBSB IB).
Business : Ageing Population To Drive Malaysia's Pharmaceutical Demand -- MBSB IB
MBSB IB, healthcare, ageing population, pharmaceut
BE Bernama 
Key points
- In a note, MBSB IB said that as the population ages, the prevalence of non-communicable diseases (NCDs) is rising sharply, creating a permanent, structural demand for pharmaceutical therapies rather than temporary demand spikes.
- “Furthermore, managing multi-morbidities in elderly patients will drive sustained volume growth across public and private healthcare, boosting demand for biologics, biosimilars, and targeted therapies,” it said.
- Therefore, MBSB IB said it will remain optimistic about the pharmaceutical subsector, given clearer pathways to medicine security in the future.
Sentences selected automatically from the original article by Bernama.
Read the full story on Bernama That's the opening of the story. The full piece is published by Bernama.
Continue reading ↗ Story details
- Published
- Section
- news
- Format
- Article
- Original
- bernama.com ↗
Related reporting
6 stories on this topic from 4 sources, oldest first.
- Bernama Business : Ageing Population To Drive Malaysia's Pharmaceutical Demand -- MBSB IB (this story)